DBL Law’s ‘Made It Series’ spotlights NKY life sciences leaders
By Abigail Wright NKyTribune staff reporter Northern Kentucky business leaders discussed innovation, resilience and the region’s growing life science sector…
Bexion Pharmaceuticals
Read More
Bexion Pharmaceuticals make leadership changes, names Richard ‘Scott’ Shively new president/CEO
Bexion Pharmaceuticals, a clinical-stage biopharmaceutical company based in Covington, announced key leadership changes, including the appointment of Richard “Scott” Shively…
Legislators can ‘help us change world,’ say experts; ‘R&D lab critical to attracting biotech startups’
By Tony Remington, Gravity Diagnostics, Tim Schroeder, CTI, and Ray Takigiku, Bexion Special to NKyTribune With a single investment, the…
Bexion Pharmaceuticals advances clinical development of BXQ-350 in rare pediatric tumors
NKyTribune staff Covington-based Bexion Pharmaceuticals, Inc. an oncology-focused company, has announced the completion of a Type B Pre-IND in-person meeting…
Bexion Pharmaceuticals announces significant regulatory milestone toward Phase 2 cancer trial
Covington-based Bexion Pharmaceuticals, Inc. an oncology-focused company, Tuesday announced the completion of a Type B End-of-Phase 1 meeting with the…
Bexion Pharmaceuticals announces the opening of study using BXQ-350 in treatment of rare tumors
Covington-based Bexion Pharmaceuticals, Inc., a clinical stage oncology company, has announced the initiation of an open-label Phase 1 Safety Study…
Experts discuss innovations, treatments and new possibilities in cancer care in Northern Kentucky
By David Kubota NKyTribune reporter A panel of representatives from local cancer companies and researchers gathered to speak about cancer…
Bexion Pharmaceuticals, Inc. announces data from ongoing Phase I BXQ-350 clinical trial
Covington-based Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on rare brain and solid tumors, discussed data from 17 patients…
Power in Numbers symposium shines spotlight on opportunity identified in Transfer of Wealth study
By Mark Hansel NKyTribune managing editor The Power in Numbers symposium at the St. Elizabeth Healthcare Training and Education Center…
Gov. Bevin in Covington Thursday for Thomas More College Work Ready Incubator ribbon cutting
By Mark Hansel NKyTribune managing editor Gov. Matt Bevin was in Covington Thursday to cut the ribbon on the Thomas…
Bexion Pharmaceuticals, CTI successfully complete first human trial on BXQ-350 treatment of cancer
Bexion Pharmaceuticals and CTI Clinical Trial and Consulting Services have successfully completed the First-in-Human Phase 1A clinical trial with BXQ-350…
NKY Chamber of Commerce Business Impact Awards recognize the large, the small and the cool
By Mark Hansel NKyTribune managing editor The Northern Kentucky Chamber of Commerce 2017 Business Impact Awards Wednesday recognized companies and…
“Innovation Alley” coming to Covington; will serve as hub of UpStart Celebration of Entrepreneurship
The Covington Board of City Commissioners has conducted a first reading of an ordinance that will name the alley that…
Bexion Pharmaceuticals gets FCA approval for a clinical trial of its first-in-class treatment of cancer
Bexion Pharmaceuticals, LLC (‘Bexion”) announced today that the U.S. Food and Drug Administration (FDA) cleared Bexion’s application to initiate a…
Covington’s Bexion Pharmaceuticals awarded SBA’s coveted Tibbetts Award for innovative research
Bexion Pharmaceuticals LLC has been awarded a “Model of Excellence” recognition by the Small Business Administration. The SBA has awarded…